Prospective Breast Cancer Biospecimen Collection

Recruiting now

Conditions studied: Breast Cancer, Invasive Breast Cancer, Carcinoma in Situ of the Breast

In brief

Tissue will be procured during a standard of care procedure the patient will already be scheduled to undergo. A one time blood draw will be performed at this time and an optional rectal swab for biome analysis may occur. Follow Up will only consist of chart review to determine date of recurrence, metastases, and/or death

Key facts

Study ID

NCT04074720

Run by

Thomas Jefferson University

People needed

200

Starts

2018-05-10

Expected to finish

2028-07-01

Last updated by the study team

2025-12-03

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adults >18 years old at time of consent
• Subject must be capable to giving informed consent or have an acceptable surrogate capable of giving consent on the subject behalf.
• Patients with carcinoma in situ or invasive breast cancer
• Patient must be undergoing one of the following:
• definitive surgical tumor resection for breast cancer OR
• placement of a vascular access device as a prelude to neoadjuvant therapy for breast cancer OR
• neurosurgical resection of a brain metastasis from primary breast cancer.

You may not qualify if…

• <18 years old
• Not able to give informed consent and does not have acceptable surrogate capable to giving informed consent.
• Active drug/alcohol dependence or abuse history

Where it is running

• Sidney Kimmel Cancer Center at Thomas Jefferson University — Philadelphia, Pennsylvania, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.